Growing Graph of IP

BOTSWANA has become the 18th country to recognize Indian Pharmacopoeia (IP) as a book of standard for medicines when it signed an MoU with the Indian government during Indian President Droupadi Murmu's recent visit to Botswana.

- 

This MoU will establish a framework for the recognition of the IP as a pharmacopoeia standard for assessing applications for market authorisation for medicinal products manufactured in India. Thus, it will significantly ease regulatory procedures and facilitate greater market access for Indian pharmaceutical products in Botswana. This growing recognition of IP reflects the growing international trust in India's robust scientific and regulatory frameworks. This recognition is expected to boost India's pharmaceutical exports to Botswana by removing the need for duplicate testing and post-importation checks. Global recognition to IP as a book of standard has been a major issue the Indian pharmaceutical exporters have been facing for a long time now. Though India is the world's largest supplier of generic medicines and accounts for 20 per cent of the worldwide supply of generic drugs by volume, very few countries accepted IP as a book of standard till early this year. But, things are now changing fast as the acceptance of IP is gathering momentum, thanks to the proactive measures